Experience of the Burden of Using Multiple Medicines and the Associated Impact on Health-Related Quality of Life.

Aastha Gurung, Edward Ogden, Won Sun Chen
Author Information
  1. Aastha Gurung: School of Health Sciences, Swinburne University of Technology, Hawthorne, Victoria, Australia. ORCID
  2. Edward Ogden: School of Health Sciences, Swinburne University of Technology, Hawthorne, Victoria, Australia.
  3. Won Sun Chen: Curtin Medical School, Curtin University, Bentley, Western Australia, Australia. ORCID

Abstract

Managing multiple medications can be challenging for many patients and negatively affect their health-related quality of life (HRQoL). This study examined the key factors that predict medication burden and HRQoL separately. The secondary aim was to investigate whether overall experience of medication burden mediates the relationship between the number of medications taken and HRQoL. A cross-sectional study was conducted with 348 participants. The average age of these participants was 31 years (SD ± 11.3 years). The average number of medications used was 3.2 (SD ± 1.6). The majority of the study participants experienced moderate (39.0%) to high (45.0%) levels of medication burden. Limited autonomy in adjusting their regimen and concerns about their medications were identified as major contributors to this burden. Hierarchical linear regression analysis indicated that overall experience of medication burden, self-rated health, and a diagnosis of diabetes mellitus significantly predicted medication burden. Similarly, self-rated health, dosing frequency, being female, and assistance with medicines were significant predictors of poor HRQoL. Mediation analysis revealed that overall experience of medication burden partially mediated the association between number of medicines used and HRQoL. These findings highlight the importance of addressing medication burden when developing interventions to avoid jeopardizing patients' HRQoL. Healthcare professionals should prioritize understanding the experiences of nonelderly patients with their medications and personalize treatment plans accordingly.

Keywords

References

  1. BMJ Open. 2016 Feb 02;6(2):e010035 [PMID: 26839015]
  2. Lancet Public Health. 2024 May;9(5):e282-e294 [PMID: 38702093]
  3. Pharm World Sci. 2008 Jan;30(1):86-91 [PMID: 17653833]
  4. Pharmacy (Basel). 2018 Aug 13;6(3): [PMID: 30104554]
  5. Aust J Gen Pract. 2021 Jan-Feb;50(1-2):43-48 [PMID: 33543163]
  6. Arch Dis Child. 2020 Dec;105(12):1192-1196 [PMID: 32868266]
  7. J Med Internet Res. 2015 Feb 24;17(2):e52 [PMID: 25803266]
  8. PLoS One. 2017 Feb 6;12(2):e0171320 [PMID: 28166266]
  9. Qual Life Res. 2024 Mar;33(3):721-733 [PMID: 38085452]
  10. JMIR Res Protoc. 2021 Aug 27;10(8):e27669 [PMID: 34448726]
  11. Appl Health Econ Health Policy. 2017 Apr;15(2):127-137 [PMID: 28194657]
  12. Health Expect. 2015 Jun;18(3):312-24 [PMID: 23363080]
  13. Prev Chronic Dis. 2022 Aug 18;19:E50 [PMID: 35980834]
  14. Expert Opin Drug Saf. 2014 Jan;13(1):57-65 [PMID: 24073682]
  15. Chronic Illn. 2023 Sep;19(3):495-513 [PMID: 35971949]
  16. PLoS One. 2022 Apr 28;17(4):e0267593 [PMID: 35482805]
  17. Am J Transl Res. 2023 May 15;15(5):3060-3066 [PMID: 37303631]
  18. Front Med (Lausanne). 2019 Oct 10;6:218 [PMID: 31649931]
  19. J Psychosom Res. 2004 Jan;56(1):75-82 [PMID: 14987967]
  20. Soc Sci Med. 2004 Sep;59(6):1307-13 [PMID: 15210101]
  21. Patient Relat Outcome Meas. 2018 May 28;9:155-168 [PMID: 29881317]
  22. JAMA. 2018 Dec 18;320(23):2461-2473 [PMID: 30561486]
  23. Breathe (Sheff). 2021 Mar;17(1):210002 [PMID: 34295406]
  24. Res Social Adm Pharm. 2021 Jan;17(1):2023-2026 [PMID: 32307319]
  25. Qual Life Res. 2011 Dec;20(10):1727-36 [PMID: 21479777]
  26. Arch Dis Child. 2010 Sep;95(9):717-23 [PMID: 20522463]
  27. Health Soc Care Community. 2018 Nov;26(6):946-959 [PMID: 30058749]
  28. Health Qual Life Outcomes. 2016 Sep 20;14(1):133 [PMID: 27644755]
  29. Mayo Clin Proc Innov Qual Outcomes. 2024 Jan 20;8(1):112-119 [PMID: 38304166]
  30. Pharm World Sci. 2010 Apr;32(2):154-61 [PMID: 20043241]
  31. BMC Geriatr. 2022 Jul 19;22(1):601 [PMID: 35854209]
  32. BMC Womens Health. 2023 Apr 6;23(1):162 [PMID: 37024841]
  33. Appl Health Econ Health Policy. 2013 Jun;11(3):287-98 [PMID: 23649892]
  34. Qual Life Res. 2020 Apr;29(4):977-986 [PMID: 31786690]
  35. Pharmacy (Basel). 2019 Feb 02;7(1): [PMID: 30717323]
  36. Patient Prefer Adherence. 2019 Dec 20;13:2171-2184 [PMID: 31908424]
  37. Front Pharmacol. 2020 Aug 21;11:1296 [PMID: 32973523]
  38. BMC Fam Pract. 2019 Jun 28;20(1):88 [PMID: 31253097]
  39. J Hum Hypertens. 2012 Jun;26(6):374-80 [PMID: 21593782]

Word Cloud

Created with Highcharts 10.0.0burdenmedicationHRQoLmedicationsqualitylifestudyoverallexperiencenumberparticipantspatientshealth-relatedaverageyears3used0%analysisself-ratedhealthmedicinesManagingmultiplecanchallengingmanynegativelyaffectexaminedkeyfactorspredictseparatelysecondaryaiminvestigatewhethermediatesrelationshiptakencross-sectionalconducted348age31SD ± 112SD ± 16majorityexperiencedmoderate39high45levelsLimitedautonomyadjustingregimenconcernsidentifiedmajorcontributorsHierarchicallinearregressionindicateddiagnosisdiabetesmellitussignificantlypredictedSimilarlydosingfrequencyfemaleassistancesignificantpredictorspoorMediationrevealedpartiallymediatedassociationfindingshighlightimportanceaddressingdevelopinginterventionsavoidjeopardizingpatients'HealthcareprofessionalsprioritizeunderstandingexperiencesnonelderlypersonalizetreatmentplansaccordinglyExperienceBurdenUsingMultipleMedicinesAssociatedImpactHealth-RelatedQualityLifemedicine-related

Similar Articles

Cited By